Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Wilex hands back some cancer drugs as it circles the biotech drain

22/05/2014 by

W1siziisijiwmtqvmtavmjgvmtuvndevmtmvmzg4l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

Germany’s Wilex is emptying its pockets of drug candidates, giving 5 once-promising cancer treatments back to partner UCB as it pares down to stay alive.

The biotech will relinquish its rights to the mid-stage WX-554 and WX-037 and give back three preclinical antibody therapies, terminating a separate, non-oncology development deal with UCB in the process, Wilex said. The company will get a final undisclosed R&D payment from its soon-to-be-ex-collaborator, and UCB has agreed to waive repayment a €2.5 million ($3.4 million) term loan, sparing the cash-strapped Wilex from further loss.

The hand-off is part of a strategic alignment that saw Wilex cut 80% of its staff in January, kicking off a tiered exit from all clinical activity. The plan is sell off or out-license all of its proprietary assets and focus on its revenue-generating Heidelberg Pharma subsidiary, which provides preclinical CRO services and rents out Wilex’s antibody-drug conjugate technology.

This article has been extracted from http://www.fiercebiotech.com, please click on this link to read the article in full http://www.fiercebiotech.com/story/wilex-hands-back-some-cancer-drugs-it-circles-biotech-drain/2014-05-21

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdkvmjkvmdgvmtmvmjkvmjgyl1vudgl0bgvkigrlc2lnbiaomjuplmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Are PSLs a Blocker or an Enabler?

2017-10-02 11:00:00 +0100

The use of a Preferred Supplier List (PSL) was intended to support and strengthen relationships and performance between organisations and their third party suppliers. As the technical landscape continues to evolve at rapid rate recruitment and demand for new skills becomes more intense. Are PSLs still the solution or an obstacle to sourcing the right talent? The traditional PSL A dedicated list of partners intended to guarantee quality and availability ...

W1siziisijiwmtcvmdkvmjevmdgvndmvmduvmtmxl1vudgl0bgvkigrlc2lnbiaomjmplmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Why do we punish the victims of hacking?

2017-09-21 09:00:00 +0100

Hacks occur every 39 seconds, with 95% of them targeting governments, retailers and the tech industry. If the hackers are caught, they'll face prison time under the Computer Misuse Act. More often than not, the businesses who are victims of those attacks expose themselves to punishment of their own. The laws that determine the duty of protection owed to businesses and their customers is both vague and broad, making them question just how much protection...